Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.39 | 4e-08 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-06 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.2 | 0.5 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |